Clinical Trial ID: NCT05879926
NRG-BR009: A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less than or Equal to 25 (OFSET)
Status
Open
Conditions
Other
Phases
III
Age Group
Adult
Main Investiagtor
Avila-Lima, Dayra
Practice
Breast
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT05879926
Keywords
Treatment